Intranasal Administration of Self-Oriented Nanocarriers Based on Therapeutic Exosomes for Synergistic Treatment of Parkinson’s Disease

The treatment of Parkinson’s disease (PD) has been hindered by the complex pathologies and multiple membrane barriers during drug delivery. Although exosomes derived from mesenchymal stem cells (MSCs) have great potential for PD, MSC-derived exosomes alone could not fully meet the therapeutic requir...

Celý popis

Uloženo v:

Podrobná bibliografie
Vydáno v:	ACS nano Ročník 16; číslo 1; s. 869 - 884
Hlavní autoři:	Peng, Huan, Li, Yan, Ji, Weihong, Zhao, Ruichen, Lu, Zhiguo, Shen, Jie, Wu, Yanyue, Wang, Jianze, Hao, Qiulian, Wang, Jingwen, Wang, Wenli, Yang, Jun, Zhang, Xin
Médium:	Journal Article
Jazyk:	angličtina
Vydáno:	United States American Chemical Society 25.01.2022
Témata:	self-oriented nanocarrier three-pronged synergistic treatment MSC-derived exosomes multiple membrane barriers intranasal administration Parkinson’s disease
ISSN:	1936-0851, 1936-086X, 1936-086X
On-line přístup:	Získat plný text
Tagy:	Přidat tag Žádné tagy, Buďte první, kdo vytvoří štítek k tomuto záznamu!

Popis
Shrnutí:	The treatment of Parkinson’s disease (PD) has been hindered by the complex pathologies and multiple membrane barriers during drug delivery. Although exosomes derived from mesenchymal stem cells (MSCs) have great potential for PD, MSC-derived exosomes alone could not fully meet the therapeutic requirements due to their limitation in therapy and delivery. Here, we develop a self-oriented nanocarrier called PR-EXO/PP@Cur that combines therapeutic MSC-derived exosomes with curcumin. PR-EXO/PP@Cur can be self-oriented across the multiple membrane barriers and directly release drugs into the cytoplasm of target cells after intranasal administration. With enhanced accumulation of drugs in the action site, PR-EXO/PP@Cur achieves three-pronged synergistic treatment to deal with the complex pathologies of PD by reducing α-synuclein aggregates, promoting neuron function recovery, and alleviating the neuroinflammation. After treatment with PR-EXO/PP@Cur, the movement and coordination ability of PD model mice are significantly improved. These results show that PR-EXO/PP@Cur has great prospects in treatment of PD or other neurodegenerative diseases.
Bibliografie:	ObjectType-Article-1 SourceType-Scholarly Journals-1 ObjectType-Feature-2 content type line 23
ISSN:	1936-0851 1936-086X 1936-086X
DOI:	10.1021/acsnano.1c08473